Yüklüyor......
An immunogenic WT1-derived peptide that induces T cell response in the context of HLA-A*02:01 and HLA-A*24:02 molecules
The Wilms' tumor oncogene protein (WT1) is a highly validated tumor antigen for immunotherapy. WT1-targeted immunotherapy has been extensively explored in multiple human trials in various cancers. However, clinical investigations using WT1 epitopes have generally focused on two peptides, HLA-re...
Kaydedildi:
| Yayımlandı: | Oncoimmunology |
|---|---|
| Asıl Yazarlar: | , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Taylor & Francis
2016
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5353933/ https://ncbi.nlm.nih.gov/pubmed/28344864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1252895 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|